Six moderate to severe Israeli coronavirus patients have shown clinical improvement with the new opaganib treatment from Israel’s Redhill (see here previously). All required less supplemental oxygenation, had higher lymphocyte counts and less lung inflammation.
Israeli coronavirus treatment benefits six patients
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.